No Data
No Data
Winshine Science Signs MoU to Cooperate in New Medical Aesthetics Market
Winshine Science (HKG:0209) has signed a memorandum of understanding with an independent third party to strategically cooperate in the medical field, a Tuesday filing on the Hong Kong bourse stated. U
Yingsheng Science (00209.HK) plans to jointly develop business in the new medical aesthetic market with strategic partners
Yingsheng Science (00209.HK) announced that on April 16, 2024, the company signed a memorandum of understanding with an independent third party (strategic partner) on strategic cooperation in the medical field. According to the memorandum of understanding, the two sides plan to establish a long-term strategic partnership to jointly develop business in the new medical aesthetic market, including entering the API market, with a view to achieving mutual benefit and common progress in technology in the medical field to meet the broader needs of human health.
Yingsheng Science (00209) signed a memorandum of understanding with an independent third party on strategic cooperation in the medical field
Yingsheng Science (00209) issued an announcement. On April 16, 2024, the company and an independent third party (battle...
WINSHINE SCI To Carry Out 1-for-5 Reverse Stock Split On May 24th, 2024
April 13th - $WINSHINE SCI(00209.HK)$ is about to implement a 1-for-5 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 24th, 2024.$WINSHINE SCI(00209.HK)
Yingsheng Science (00209.HK) plans to consolidate shares according to the “5 and 1” basis
Gelonghui, April 12, 丨 Yingsheng Science (00209.HK) announced that the board of directors proposed a share consolidation based on merging issued and unissued shares with a face value of HK$0.01 per five (5) shares into one (1) share with a face value of HK$0.05 per share. The board recommended that share capital reduction and share segmentation be implemented immediately after the share merger comes into effect. Based on this: (i) the company's issued share capital will be reduced by cancelling the paid-up share capital (up to the limit of HK$0.04 per share issued at the time), so that the face value of each issued consolidated share will be reduced from HK$0.05 to HK$0.01; and (
Ying Sheng Science (00209.HK): Li Zhonghai was appointed as Executive Director
Gelonghui, April 12, 丨 Yingsheng Science (00209.HK) announced that Li Zhonghai has been appointed as the company's executive director, effective April 12, 2024.
No Data